NFKB1 and neoplasm: The receptor for advanced glycation end products (RAGE) on GBM enhances neutrophil infiltration and NF-κB activation, leading to increased tumor-supportive inflammation.246 While early-stage neutrophils can exert antitumor effects via ROS production, their tumor-promoting functions dominate in advanced disease.